Jeff Yass’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-36,461
Closed -$2.73M 10589
2015
Q3
$2.73M Sell
36,461
-209,990
-85% -$15.7M ﹤0.01% 3669
2015
Q2
$18.6M Buy
246,451
+178,006
+260% +$9.54M 0.01% 1369
2015
Q1
$3.43M Buy
68,445
+49,552
+262% +$2.08M ﹤0.01% 3311
2014
Q4
$655K Buy
18,893
+9,700
+106% +$338K ﹤0.01% 6696
2014
Q3
$301K Sell
9,193
-15,028
-62% -$529K ﹤0.01% 8027
2014
Q2
$929K Buy
24,221
+15,660
+183% +$547K ﹤0.01% 6203
2014
Q1
$340K Buy
8,561
+2,319
+37% +$104K ﹤0.01% 7407
2013
Q4
$233K Sell
6,242
-4,841
-44% -$201K ﹤0.01% 8016
2013
Q3
$506K Buy
+11,083
New +$331K ﹤0.01% 6405

Jeff Yass's KYTH Position: Q4 2015 in Review

Jeff Yass sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 36,461 shares — an estimated $2.73M sold.

Jeff Yass first reported a position in KYTH in Q3 2013 and held it in 9 quarters. The position peaked at $18.6M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Jeff Yass reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Jeff Yass sold 36,461 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $2.73M.
  • Jeff Yass first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2013 and held it in 9 quarters.
  • Jeff Yass's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $18.6M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Susquehanna International Group's 13F filing for Q4 2015, filed 16 Feb 2016.